Morning Overview on MSN
China’s crewed moon landing plans look increasingly credible
China’s program to put astronauts on the lunar surface by 2030 has moved from aspiration to engineering reality, with hardware tests, named spacecraft, and a defined mission architecture now on the ...
The annual show for the embedded electronics supply chain showcased many innovations in edge AI and connected, intelligent systems that can perceive and act in real time.
The Next Generation, Falling Skies, and Battlestar Galactica are some of the sci-fi shows that get better with every rewatch.
Mercury Systems, Inc. (NASDAQ: MRCY, a global technology company that delivers mission-critical processing to the edge, today announced the acquisition of SolderMask, Inc., a provider of specialized ...
S&P Global announced that four companies will join the S&P 500 index as part of its quarterly rebalance. The additions highlight the rising importance of AI infrastructure within the leading US equity ...
Bicara Therapeutics (NASDAQ:BCAX) is developing tumor-targeting bifunctional antibodies, with its lead candidate ficerasfusp alfa designed to address both EGFR and TGF-beta biology in cancer, company ...
Explore the latest colorectal cancer treatment advances, from precision oncology and immunotherapy to ADCs, bispecifics, and T-cell engagers.
Morning Overview on MSN
Giant tyrannosaur fossil in North America is largest of its era
A fossil tyrannosaur pulled from the badlands of southern New Mexico has forced paleontologists to rethink when giant ...
Saudi Arabia can push 7 million barrels a day through the Petroline. Its export terminal can load less than half that. The gap was seemingly always the plan.
G&A Expenses -- $13.8 million in the fourth quarter, of which $5.6 million was non-cash stock-based compensation; annual G&A ...
The AWS AI Agent Incidents This report reviews the breaking news about AWS AI outages, analyzes architectural failure modes, and demonstrates how ColorTokens Xshield microsegmentation, designed to ...
Allogene Therapeutics, Inc. (NASDAQ:ALLO) Q4 2025 Earnings Call Transcript March 12, 2026 Allogene Therapeutics, Inc. beats earnings expectations. Reported EPS is $-0.17, expectations were $-0.22551.
一些您可能无法访问的结果已被隐去。
显示无法访问的结果